Asaf Stolovy - Human Xtensions Chief Officer

All Insiders . Israel . 
Stock . Human Xtensions . Stakeholders . Insider . Asaf Stolovy
HUMX Stock  ILA 31.00  1.90  6.53%   

Insider

Asaf Stolovy is Chief Officer of Human Xtensions
Age 47
Phone972 7 363 0300
Webhttps://human-x.com

Human Xtensions Management Efficiency

The company has return on total asset (ROA) of (0.2713) % which means that it has lost $0.2713 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5004) %, meaning that it generated substantial loss on money invested by shareholders. Human Xtensions' management efficiency ratios could be used to measure how well Human Xtensions manages its routine affairs as well as how well it operates its assets and liabilities.
Human Xtensions has accumulated 7.55 M in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Human Xtensions has a current ratio of 16.5, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Human Xtensions until it has trouble settling it off, either with new capital or with free cash flow. So, Human Xtensions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Human Xtensions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Human to invest in growth at high rates of return. When we think about Human Xtensions' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Lilach GevaHarelICL Israel Chemicals
43
Arnon SalomonSeach Medical Group
51
Maya GrinfeldICL Israel Chemicals
N/A
Aryhe CPAHarel Insurance Investments
49
Alon ElirazHarel Insurance Investments
52
Amir MeshulamICL Israel Chemicals
43
Ofir SaridSeach Medical Group
43
Nataly MishanZakaiHarel Insurance Investments
49
Aya LandmanICL Israel Chemicals
N/A
Tzipi OzerArmonICL Israel Chemicals
53
Dalit WeichselbaumSeach Medical Group
47
Nitzan LotringerSeach Medical Group
N/A
Batel LachmiCohenlAmot Investments
38
Nitzan MosheICL Israel Chemicals
52
Jacob AmidrorSeach Medical Group
71
Nir CohenHarel Insurance Investments
52
Sammy BassatHarel Insurance Investments
76
Noam GoldsteinICL Israel Chemicals
62
Margalit SaridSeach Medical Group
38
Ohad WeissAmot Investments
45
Ofer ZurAmot Investments
N/A
It offers HandX, a handheld medical device for use in laparoscopic procedures. The company was founded in 2012 and is based in Netanya, Israel. HUMAN XTENSIONS operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 58 people. Human Xtensions (HUMX) is traded on Tel Aviv Stock Exchange in Israel and employs 72 people.

Management Performance

Return On Equity-0.5
Return On Asset-0.27

Human Xtensions Leadership Team

Elected by the shareholders, the Human Xtensions' board of directors comprises two types of representatives: Human Xtensions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Human. The board's role is to monitor Human Xtensions' management team and ensure that shareholders' interests are well served. Human Xtensions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Human Xtensions' outside directors are responsible for providing unbiased perspectives on the board's policies.
Asaf Stolovy, Chief Officer
Amir MD, Chief Officer
Barak Klein, Chief Officer
Alon Heth, VP Sales
Tami Frenkel, CoFounder Director
Ronen Castro, Chief Officer
Hagar Lisser, Human Director

Human Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Human Xtensions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.5
Return On Asset-0.27
Operating Margin(14.93) %
Current Valuation(47.61 M)
Shares Outstanding26.76 M
Shares Owned By Insiders55.22 %
Shares Owned By Institutions9.62 %
Price To Book0.27 X
Price To Sales6.20 X
Revenue3.12 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Other Information on Investing in Human Stock

Human Xtensions financial ratios help investors to determine whether Human Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Human with respect to the benefits of owning Human Xtensions security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY